facebook

twitter

youtube

linkedin

Home - News and Events - News - European Medicines Agency (EMA) in Amsterdam

November 16 2017

European Medicines Agency (EMA) in Amsterdam

SHARE

téléchargement

It was announced on November 20^th, 2017 that the European Medicines Agency (EMA) will relocate to Amsterdam. This agency plays a crucial role in the development and authorization of orphan medicines in Europe. Orphan medicines are medicinal products intended for the diagnosis, prevention or treatment of rare diseases. Wishing them all the best in their new home!

Read the official press release here

New HTAD Gene Compendia Released

VASCERN HTAD WG launches gene compendia for Heritable Thoracic Aortic Diseases

REDS4VEDS Day 2025: 10 years of awareness, advocacy, and the push for better care

Headaches in Moyamoya Angiopathy Thumbnail

Webinar Replay: Headache in patients with Moyamoya Angiopathy

Booklet Mockup 3

Pregnancy, Family Planning & Vascular Anomalies Booklet Now Available

Key Updates from the Medium Sized Arteries Spring Meeting 2025 in Rotterdam

Highlights from the Heritable Thoracic Aortic Diseases (HTAD) Spring Meeting 2025 in Brussels

vasca magazine online article

VASCA Magazine moves online – Discover the first article!

Exchange Program Interview

Barcelona_visit_exchange_2024

Exchange Programme Interview: Dr. Daan Bosshardt

YouTube thumbnail (12)

Patient Testimonial of Alejandro, Living with Lymphoedema